Carnegie acted as joint bookrunner in the directed new share issue of 4,000,000 shares at a subscription price of SEK 67.5 per share. Q-linea is a diagnostic company focused on developing and delivering solutions for healthcare providers, enabling them to accurately diagnose and treat infectious diseases in the shortest possible time. June 2020.
Healthcare
Directed share issue in Q-linea AB (SE) — SEK 270 million
June 2020